Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 May 1;34(5):349-357.
doi: 10.1097/IJG.0000000000002535. Epub 2025 Jan 16.

Comparison of Outcomes of Deep Sclerectomy, Canaloplasty, and Viscocanaloplasty: A Multicenter Study

Karl Mercieca  1   2 , Matthew Azzopardi  3 , Neeru A Vallabh  4   5 , Cristina Cristian  6 , Verena Prokosch  7 , Vincent Dubois  8 , Christopher Hemmerdinger  9   10 , Stefano De Cillà  11   12 , Divya Mathews  13 , Andre Mermoud  14 , Matthias C Grieshaber  15   16 , Gordana Sunaric Mégevand  17   18 , Nitin Anand  19   20 , Alessandro Rabiolo  11   12
Affiliations
Comparative Study

Comparison of Outcomes of Deep Sclerectomy, Canaloplasty, and Viscocanaloplasty: A Multicenter Study

Karl Mercieca et al. J Glaucoma. .

Abstract

Prcis: Deep sclerectomy (DS) and canaloplasty provide better intraocular pressure (IOP) control than viscocanalostomy. DS required less glaucoma medications but more interventions to reach the target IOP.

Purpose: To compare real-world outcomes of 3 non-penetrating glaucoma surgery (NPGS) techniques.

Methods: Retrospective, cohort study of consecutive patients undergoing canaloplasty (CP), deep sclerectomy (DS), and viscocanalostomy (VC), across 9 European glaucoma units. Four intraocular pressure (IOP) criteria were used to define success at 2-year follow-up: (A) IOP≤21 mmHg and ≥20% reduction; (B) IOP≤18 mmHg and ≥20% reduction; (C) IOP≤15 mmHg and ≥25% reduction; (D) IOP≤12 mmHg and ≥30% reduction. Secondary outcomes included IOP control, BCVA, number of medications over time, risk factors for failure, complications, and post-operative interventions. Success was distinguished as qualified or complete, if reached with or without antiglaucoma medications, respectively.

Results: Six hundred eyes (545 patients) undergoing standalone CP (201 eyes), DS (200 eyes), and VC (199 eyes) were included. Qualified success rates of CP, DS, and VP at 24 months were, respectively: (criterion A) 85.1%, 67.6%, and 64.6%; (criterion B) 85.1%, 66.1%, and 58.6%; (criterion C) 76.6%, 55.5%, and 39.0%; (criterion D) 27.7%, 28.5%, and 22.1%. Success rates were significantly different across the 3 techniques ( P =0.04 or below), except for complete success according to criterion A ( P =0.07). Mean IOP(±SD) reduced from 25.2 (±6.9), 20.5 (±6.7), and 22.7 (±7.2)mmHg preoperatively to 13.1 (±3.1), 12.9 (±4.5), and 14.7 (±4.6)mmHg at postoperative year 2 in the CP, DS, and VC groups, respectively ( P <0.001 between preoperative and postoperative time points for all groups).

Conclusions: All 3 NPGS provide sustained IOP reduction, but DS and CP provide better success rates and IOP control. Success rates were low for the most stringent cutoffs, suggesting that other techniques such as trabeculectomy may be indicated when a very low target IOP is demanded.

Keywords: canaloplasty; deep sclerectomy; glaucoma; non-penetrating glaucoma surgery; viscocanalostomy.

PubMed Disclaimer

Conflict of interest statement

Disclosure: A.R. has stocks in Apellis Pharmaceutical. The remaining authors declare no conflict of interest.

References

    1. Rathi S, Andrews CA, Greenfield DS, et al. Trends in glaucoma surgeries performed by glaucoma subspecialists versus nonsubspecialists on medicare beneficiaries from 2008 through 2016. Ophthalmology. 2021;128:30–38.
    1. Dwivedi R, Somerville T, Cheeseman R, et al. Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes. Graefes Arch Clin Exp Ophthalmol. 2021;259:1965–1974.
    1. Fyodorov SN. Nonpenetrating deep sclerectomy in open angle glaucoma. Ophthalmosurgery. 1989;3:52–55.
    1. Rabiolo A, Leadbetter D, Alaghband P, et al. Primary deep sclerectomy in open-angle glaucoma: long-term outcomes and risk factors for failure. Ophthalmol Glaucoma. 2021;4:149–161.
    1. Bull H, von Wolff K, Körber N, et al. Three-year canaloplasty outcomes for the treatment of open-angle glaucoma: European study results. Graefes Arch Clin Exp Ophthalmol. 2011;249:1537–1545.